A detailed history of Eagle Asset Management Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Eagle Asset Management Inc holds 27,456 shares of TEVA stock, worth $469,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,456
Previous 26,615 3.16%
Holding current value
$469,772
Previous $375,000 18.93%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$12.78 - $17.4 $10,747 - $14,633
841 Added 3.16%
27,456 $446,000
Q1 2024

May 09, 2024

BUY
$10.67 - $14.43 $283,982 - $384,054
26,615 New
26,615 $375,000
Q4 2021

Feb 11, 2022

SELL
$7.9 - $10.19 $139,356 - $179,751
-17,640 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$8.38 - $10.18 $14,354 - $17,438
1,713 Added 10.76%
17,640 $171,000
Q2 2021

Aug 11, 2021

BUY
$9.9 - $11.56 $9,276 - $10,831
937 Added 6.25%
15,927 $157,000
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $93,959 - $116,404
9,087 Added 153.94%
14,990 $172,000
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $88,846 - $113,921
-10,319 Reduced 63.61%
5,903 $56,000
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $3,993 - $5,913
-466 Reduced 2.79%
16,222 $143,000
Q2 2020

Aug 12, 2020

BUY
$8.12 - $13.12 $135,506 - $218,946
16,688 New
16,688 $203,000
Q3 2019

Nov 04, 2019

SELL
$6.16 - $9.6 $113,473 - $176,841
-18,421 Closed
0 $0
Q2 2019

Aug 05, 2019

SELL
$8.12 - $15.72 $8,737 - $16,914
-1,076 Reduced 5.52%
18,421 $170,000
Q1 2019

May 01, 2019

BUY
$15.58 - $20.01 $22,232 - $28,554
1,427 Added 7.9%
19,497 $305,000
Q4 2018

Feb 11, 2019

BUY
$14.59 - $23.84 $52,407 - $85,633
3,592 Added 24.81%
18,070 $278,000
Q3 2018

Nov 08, 2018

BUY
$21.06 - $25.65 $304,906 - $371,360
14,478 New
14,478 $342,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.